Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of controlled ovarian hyperstimulation: time to corroborate the clinical utility of FSH receptor genetic markers.

Pharmacogenomics - 1 Nov 2010

Morón Francisco Jesús, Ruiz Agustín

Abstract excerpt

Several studies have shown high variability in clinical outcome among women undergoing follicle-stimulating hormone treatment. Pharmacogenetic studies have revealed a series of genetic markers involved in controlled ovarian hyperstimulation (COH) response. FSHR gene-associated SNPs, including the N680S missense variant, are the most promising genetic markers available to date. In this paper the state of the art...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to FSHR gene
Share to Genetic Markers
Share to Ovarian function and disorders

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Ovulation Induction

Share to Pharmacogenetics

Share to Polymorphism, Single Nucleotide

Share to Receptors, FSH

Share to Recombinant Proteins

Source

Identifiers

PMID: 21121812
DOI: 10.2217/pgs.10.156

Genes

FSHR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of controlled ovarian hyperstimulation: time to corroborate the clinical utility of FSH receptor genetic markers.PMID 21121812Read ↗

Genetic predictors of controlled ovarian hyperstimulation: where do we stand today?Semantic proximity Read ↗

Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis.Semantic proximity Read ↗

A pharmacogenetic-driven approach for controlled ovarian hyperstimulation by FSH treatment.Semantic proximity Read ↗

The Effect of the Allelics of Ser680Asn Polymorphisms of Follicle-Stimulating Hormone Receptor Gene in IVF/ICSI Cycles: a Systematic Review and Meta-analysis.Semantic proximity Read ↗

Pharmacogenetics of controlled ovarian hyperstimulation.Semantic proximity Read ↗

The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation.Semantic proximity Read ↗

Effect of follicle-stimulating hormone receptor Asn680Ser polymorphism on the outcomes of controlled ovarian hyperstimulation: an updated meta-analysis of 16 cohort studies.Semantic proximity Read ↗

Pharmacogenetics of FSH Action in the FemaleSemantic proximity Read ↗

Pharmacogenetics in ovarian stimulation - current concepts and future options.Semantic proximity Read ↗

Evaluating influence of the genotypes in the follicle-stimulating hormone receptor (FSHR) Ser680Asn (rs6166) polymorphism on poor and hyper-responders to ovarian stimulation: a meta-analysis.Semantic proximity Read ↗

Pharmacogenetics in ovarian stimulation--current concepts.Semantic proximity Read ↗

Genetic profile of SNP(s) and ovulation induction.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.